Your browser doesn't support javascript.
loading
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Lu, You; Xue, Jianxin; Deng, Tao; Zhou, Xiaojuan; Yu, Kun; Deng, Lei; Huang, Meijuan; Yi, Xin; Liang, Maozhi; Wang, Yu; Shen, Haige; Tong, Ruizhan; Wang, Wenbo; Li, Li; Song, Jin; Li, Jing; Su, Xiaoxing; Ding, Zhenyu; Gong, Youling; Zhu, Jiang; Wang, Yongsheng; Zou, Bingwen; Zhang, Yan; Li, Yanying; Zhou, Lin; Liu, Yongmei; Yu, Min; Wang, Yuqi; Zhang, Xuanwei; Yin, Limei; Xia, Xuefeng; Zeng, Yong; Zhou, Qiao; Ying, Binwu; Chen, Chong; Wei, Yuquan; Li, Weimin; Mok, Tony.
Afiliación
  • Lu Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. radyoulu@hotmail.com.
  • Xue J; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Deng T; Chengdu MedGenCell, Co., Ltd, Chengdu, China.
  • Zhou X; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Yu K; Chengdu MedGenCell, Co., Ltd, Chengdu, China.
  • Deng L; Jacobi Medical Center, NYC Health Hospitals, Albert Einstein College of Medicine, New York, NY, USA.
  • Huang M; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Yi X; Geneplus-Beijing Institute, Beijing, China.
  • Liang M; Center of GCP, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; ZenRhyme Consulting Service, Ltd, Shanghai, China.
  • Shen H; ZenRhyme Consulting Service, Ltd, Shanghai, China.
  • Tong R; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang W; National Research Center for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li L; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Song J; Geneplus-Beijing Institute, Beijing, China.
  • Li J; Geneplus-Beijing Institute, Beijing, China.
  • Su X; Berry Oncology Co. Ltd, Fujian, China.
  • Ding Z; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Gong Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhu J; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zou B; Center of GCP, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Li Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhou L; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Liu Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Yu M; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang X; Geneplus-Beijing Institute, Beijing, China.
  • Yin L; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Xia X; Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zeng Y; Geneplus-Beijing Institute, Beijing, China.
  • Zhou Q; Chengdu MedGenCell, Co., Ltd, Chengdu, China.
  • Ying B; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Chen C; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Wei Y; State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Li W; State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Mok T; Department of Respiratory and Critical Care Medicine and Frontier Science Center of Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Nat Med ; 26(7): 1149, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32555427
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: China